These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36860327)

  • 21. A Cross-Sectional Study of the Correlation Between the Atherogenic Index of Plasma and Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes.
    Lin J; Li H; Wan Q
    Diabetes Metab Syndr Obes; 2022; 15():2227-2234. PubMed ID: 35936051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Atherogenic Index of Plasma With Retinopathy and Nephropathy in Adult Patients With Type 2 Diabetes Mellitus Aged > 18 Years.
    Xu J; Zhou H; Xiang G
    Can J Diabetes; 2022 Apr; ():. PubMed ID: 35927171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between vitamin D status and vascular complications in patients with type 2 diabetes mellitus.
    Jung CH; Kim KJ; Kim BY; Kim CH; Kang SK; Mok JO
    Nutr Res; 2016 Feb; 36(2):117-24. PubMed ID: 26826427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women.
    Wu TT; Gao Y; Zheng YY; Ma YT; Xie X
    Lipids Health Dis; 2018 Aug; 17(1):197. PubMed ID: 30134981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D insufficiency and its association with adipokines and atherogenic indices in patients with metabolic syndrome: A case-control study.
    Amirkhizi F; Khademi Z; Hamedi Shahraki S; Rahimlou M
    Front Endocrinol (Lausanne); 2023; 14():1080138. PubMed ID: 36742396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low Vitamin D Serum Level Is Associated with HDL-C Dyslipidemia and Increased Serum Thrombomodulin Levels of Insulin-Resistant Individuals.
    Saheb Sharif-Askari F; Saheb Sharif-Askari N; Halwani R; Abusnana S; Hamoudi R; Sulaiman N
    Diabetes Metab Syndr Obes; 2020; 13():1599-1607. PubMed ID: 32494176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pioglitazone reduces atherogenic index of plasma in patients with type 2 diabetes.
    Tan MH; Johns D; Glazer NB
    Clin Chem; 2004 Jul; 50(7):1184-8. PubMed ID: 15117857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum vitamin d status and its relationship to metabolic parameters in patients with type 2 diabetes mellitus.
    Yu JR; Lee SA; Lee JG; Seong GM; Ko SJ; Koh G; Kong MH; Park KY; Kim BJ; Lim DM; Lee DH
    Chonnam Med J; 2012 Aug; 48(2):108-15. PubMed ID: 22977752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Body weight and waist circumference as predictors of vitamin D deficiency in patients with type 2 diabetes and cardiovascular disease.
    Kavarić S; Vuksanović M; Bozović D; Jovanović M; Jeremić V; Radojicić Z; Pekić S; Popović V
    Vojnosanit Pregl; 2013 Feb; 70(2):163-9. PubMed ID: 23607183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Prevalence of Hypovitaminosis D in Postmenopausal Women with Type 2 Diabetes Mellitus.
    Raška I; Rašková M; Zikán V; Škrha J
    Prague Med Rep; 2016; 117(1):5-17. PubMed ID: 26995199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Relationship Between Triglyceride Glucose Index and Vitamin D in Type 2 Diabetes Mellitus.
    Jia Y; Song T; Li Z; Zhou L; Chen S
    Diabetes Metab Syndr Obes; 2022; 15():511-525. PubMed ID: 35221702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D Deficiency in Relation to the Risk of Metabolic Syndrome in Middle-Aged and Elderly Patients with Type 2 Diabetes Mellitus.
    Pan GT; Guo JF; Mei SL; Zhang MX; Hu ZY; Zhong CK; Zeng CY; Liu XH; Ma QH; Li BY; Qin LQ; Zhang ZL
    J Nutr Sci Vitaminol (Tokyo); 2016; 62(4):213-219. PubMed ID: 27725405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SGLT2 inhibitors improve plasma atherogenic biomarkers in patients with type 2 diabetes: a real-world retrospective observational study.
    Imre E; Gunhan HG; Erel P; Ustay O
    Minerva Endocrinol (Torino); 2023 Sep; 48(3):295-304. PubMed ID: 33979071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between vitamin D status and diabetic foot in patients with type 2 diabetes mellitus.
    Tang W; Chen L; Ma W; Chen D; Wang C; Gao Y; Ran X
    J Diabetes Investig; 2022 Jul; 13(7):1213-1221. PubMed ID: 35191197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D Deficiency May Not Be an Independent Risk Factor for Peripheral Arterial Disease in Middle-Aged and Elderly Patients with Type 2 Diabetes in China.
    Wang Y; Feng T; Zhou H; Lu K; Bai Y; Zhang P
    Dis Markers; 2020; 2020():8854717. PubMed ID: 33299499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Vitamin D Deficiency and Vitamin D Receptor Genetic Variants With Coronary Artery Disease in Type 2 Diabetic Saudi Patients.
    Shafie A; Askary AE; Almehmadi M; Allam HH; Elsayyad LK; Hassan AF; Althobaiti BB; Nadheef A; Alharthi AH; Gharib AF
    In Vivo; 2022; 36(3):1444-1452. PubMed ID: 35478145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D deficiency and cardiovascular risk in type 2 diabetes population.
    Pokhrel S; Giri N; Pokhrel R; Pardhe BD; Lamichhane A; Chaudhary A; Bhatt MP
    Open Life Sci; 2021; 16(1):464-474. PubMed ID: 34017921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of Serum Retinol and Atherogenic Indices in Type 2 Diabetes Mellitus: A Case-Control Study.
    Jyothi CCX; Bandyopadhyay D; Sahu S; Patro BK; Nayak S
    Indian J Clin Biochem; 2022 Jan; 37(1):100-106. PubMed ID: 35125699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum 25-hydroxyvitamin D concentration and its association with glucose intolerance in an indigenous population.
    Abrahão GP; Santos MC; Vieira Filho JPB; Dal Fabbro AL; Franco LJ; Moises RS
    Clin Nutr; 2021 Mar; 40(3):1318-1322. PubMed ID: 32900517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-density lipoprotein cholesterol-to-apolipoprotein B ratio as a potential indicator of LDL particle size and plasma atherogenicity in type 2 diabetes.
    Viktorinova A; Malickova D; Svitekova K; Choudhury S; Krizko M
    Diabetes Res Clin Pract; 2021 Jun; 176():108858. PubMed ID: 34015391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.